Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Doshi

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
The Cochrane Database of Systematic Reviews|January 20, 2012
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenTom Jefferson, Mark A Jones, Peter Doshi, et al.
JAMA Internal Medicine|August 23, 2017
Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011Peter Doshi, Peter Hur, Mark Jones, et al.
Msphere|November 5, 2020
Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine TrialFlorence Bourgeois, Peter Doshi, Kyungwan Hong, et al.
Journal of Law and the Biosciences|February 4, 2021
Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19Sterling Edmonds, Andrea MacGregor, Agnieszka Doll, et al.
BMJ Evidence-Based Medicine|October 13, 2018
When to include clinical study reports and regulatory documents in systematic reviewsTom Jefferson, Peter Doshi, Isabelle Boutron, et al.
BMJ Open|October 2, 2014
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reportsTom Jefferson, Mark A Jones, Peter Doshi, et al.
Systematic Reviews|August 10, 2018
The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authorsAlex Hodkinson, Kristina Charlotte Dietz, Carol Lefebvre, et al.
Health Technology Assessment (Winchester, England)|June 2, 2016
Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality dataCarl J Heneghan, Igho Onakpoya, Mark A Jones, et al.
The Cochrane Database of Systematic Reviews|April 11, 2014
Neuraminidase inhibitors for preventing and treating influenza in adults and childrenTom Jefferson, Mark A Jones, Peter Doshi, et al.
Annals of Internal Medicine|July 15, 2024
Development and Evaluation of a Framework for Identifying and Addressing Spin for Harms in Systematic Reviews of InterventionsRiaz Qureshi, Kevin Naaman, Nicolas G Quan, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
The Cochrane Database of Systematic Reviews|January 20, 2012
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and childrenTom Jefferson, Mark A Jones, Peter Doshi, et al.
JAMA Internal Medicine|August 23, 2017
Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011Peter Doshi, Peter Hur, Mark Jones, et al.
Msphere|November 5, 2020
Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine TrialFlorence Bourgeois, Peter Doshi, Kyungwan Hong, et al.
Journal of Law and the Biosciences|February 4, 2021
Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19Sterling Edmonds, Andrea MacGregor, Agnieszka Doll, et al.
BMJ Evidence-Based Medicine|October 13, 2018
When to include clinical study reports and regulatory documents in systematic reviewsTom Jefferson, Peter Doshi, Isabelle Boutron, et al.
BMJ Open|October 2, 2014
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reportsTom Jefferson, Mark A Jones, Peter Doshi, et al.
Systematic Reviews|August 10, 2018
The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authorsAlex Hodkinson, Kristina Charlotte Dietz, Carol Lefebvre, et al.
Health Technology Assessment (Winchester, England)|June 2, 2016
Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality dataCarl J Heneghan, Igho Onakpoya, Mark A Jones, et al.
The Cochrane Database of Systematic Reviews|April 11, 2014
Neuraminidase inhibitors for preventing and treating influenza in adults and childrenTom Jefferson, Mark A Jones, Peter Doshi, et al.
Annals of Internal Medicine|July 15, 2024
Development and Evaluation of a Framework for Identifying and Addressing Spin for Harms in Systematic Reviews of InterventionsRiaz Qureshi, Kevin Naaman, Nicolas G Quan, et al.
Pageof 15